Aditxt Quote - ADTX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.20

Bid

1.19

Offer

1.21

Volume

33,337

0.00 Day's Range 0.00

0.0915 52 Week Range 13.70

Market Cap

4.323M

Previous Close

1.21

Open

Last Trade

1.19

Last Trade Time

21:40:59

Financial Volume

VWAP

Average Volume (3m)

4,599,835

Shares Outstanding

3,602,861

Dividend Yield

PE Ratio

-0.13

Earnings Per Share (EPS)

-9.08

Revenue

645k

Net Profit

-32.7M

Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantatio... Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aditxt.com

Headquarters

Camden, Delaware, USA

Founded

Aditxt Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ADTX. The last closing price for Aditxt was US$1.21. Over the last year, Aditxt shares have traded in a share price range of US$ 0.0915 to US$ 13.70.

Aditxt currently has 3,602,861 shares in issue. The market capitalisation of Aditxt is US$4.36 million. Aditxt has a price to earnings ratio (PE ratio) of -0.13.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.89	-42.5837320574	2.09	3.1	1.17	11392797	1.58519936	CS
4	0.71	144.897959184	0.49	5.12	0.0915	7307668	0.77902376	CS
12	-0.84	-41.1764705882	2.04	5.12	0.0915	4599835	1.00246588	CS
26	-2.0177	-62.7062808839	3.2177	5.12	0.0915	2382796	1.13537457	CS
52	-10.31	-89.574283232	11.51	13.7	0.0915	1615326	2.25016752	CS
156	-69.6	-98.3050847458	70.8	1139.6	0.0915	2186786	30.14731644	CS
260	-210	-99.4318181818	211.2	1139.6	0.0915	2254027	63.80257263	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BLMZBloomZ Inc	US$ 1.17 (63.59%)	2.02M
TVGNTevogen Bio Holdings Inc	US$ 0.3899 (50.37%)	8.57M
CNEYCN Energy Group Inc	US$ 0.7556 (43.43%)	5.23M
ALLKAllakos Inc	US$ 0.86 (32.29%)	9
BDRXBiodexa Pharmaceuticals PLC	US$ 6.00 (25.26%)	1
TOIIWOncology Institute Inc	US$ 0.0155 (-38.98%)	218
GRTSGritstone bio Inc	US$ 0.1249 (-37.05%)	1.5M
TXG10x Genomics Inc	US$ 15.96 (-23.31%)	108.2k
KLTOKlotho Neurosciences Inc	US$ 0.4005 (-22.97%)	7.42k
CETXCemtrex Inc	US$ 0.563 (-20.70%)	440.3k
JTAIJet AI Inc	US$ 0.1079 (16.52%)	12.28M
TVGNTevogen Bio Holdings Inc	US$ 0.3899 (50.37%)	8.57M
CNEYCN Energy Group Inc	US$ 0.7556 (43.43%)	5.23M
KXINKaixin Holdings	US$ 0.2724 (10.28%)	3.61M
DUOFangDD Network Group Ltd	US$ 2.04 (15.91%)	2.94M